Loading…
← CockpitCompetitor Analysis › 300111.SZ Zhejiang Sunflower Great Health Co., Ltd Class AOpen in the cockpit ↗

Zhejiang Sunflower Great Health Co., Ltd Class A300111.SZCompetitor analysis, valuation and peers

China · CNY·Industrials›Electrical Products
Momentum leader 89
Mkt cap
$635M
US dollars, full cap
Free float
80%
of shares outstanding
$/day
$74.4M
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
-9.6 pp
WACC 7.5%
Hurdle
n/a
no reverse DCF
Close · CNYCN¥3.29
1D-3.2%
1W+5.5%
1M+10.8%
3M+13.8%
6M-15.2%
YTD-46.3%
1Y-59.2%
ATR %7.5%
52w lowhigh67.0% off high

What Zhejiang Sunflower Great Health does

Employees: 303

Zhejiang Sunflower Great Health at a glance

Size Zhejiang Sunflower Great Health (300111.SZ) is a China Industrials company (Electrical Products) with a market value of $635M, the 3283rd largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥3.29 on 6 Nov 2026.

Performance Over six months the shares fell 15.2%, against -36.5% for the median peer and -16.4% for the China market (cap-weighted) — 5th highest of 21 in its peer set.

Growth Revenue fell 19.6% over the last twelve months (peer median +20.7%); the operating margin is -9.8% (peer median 3.6%).

Valuation It trades at 16.2× enterprise value to sales against a peer median of 2.2× (3rd most expensive of 21).

Capital Return on invested capital runs 9.6 points below its cost of capital (7.5% WACC).

Relative performance

608010011 May 202611 Aug 20266 Nov 2026300111.SZ 83Peer median 62
Six months, rebased to 100: Zhejiang Sunflower Great Health against the median of its 20 peers (local-currency closes).

Zhejiang Sunflower Great Health financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥244MCN¥270MCN¥330MCN¥338MCN¥335M
Revenue growth—-18%-2%+1%—
Gross profitCN¥56.1MCN¥48.8MCN¥66.0MCN¥75.5MCN¥85.9M
EBITDAn/aCN¥4.31MCN¥10.1MCN¥31.9MCN¥13.9M
Net income-CN¥21.3M-CN¥4.38MCN¥7.83MCN¥21.7M-CN¥1.14M
Free cash flow-CN¥37.7M-CN¥5.56MCN¥18.5M-CN¥7.43M-CN¥18.0M
Capital expenditureCN¥5.71MCN¥9.76MCN¥12.9MCN¥10.3MCN¥42.1M
Total debtCN¥49.7MCN¥59.0MCN¥93.0MCN¥111MCN¥109M

Quarterly statements and history in the cockpit →

Zhejiang Sunflower Great Health competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-60%-40%-20%0%-20%0%002196EOSE603097POWERICA68827500211260301660121830118236170025601514ENVX688345301387603400082920NNE301012300626300111.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. Zhejiang Sunflower Great Health is the large dot.

Fundamentals: revenue growth against valuation

0%+200%+400%0×10×20×002196EOSE6030976882756030163011823617002560ENVX603400300626300111.SZRevenue growth (TTM) →EV / Sales →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Zhejiang Sunflower Great Health is the large dot.

Zhejiang Sunflower Great Health competitors and peer comparison

How Zhejiang Sunflower Great Health compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Zhejiang Sunflower Great Health against its 20 peers (data as of 6 Nov 2026)
Measure300111.SZPeer medianRank in peer set
1-month return+10.8%-15.6%highest of 21
6-month return-15.2%-36.5%5th highest of 21
Distance from 52-week high-67.0%-54.5%7th lowest of 21
Revenue growth (TTM)-19.6%+20.7%lowest of 20
Operating margin-9.8%3.6%5th lowest of 21
EV / Sales16.2×2.2×3rd most expensive of 21
ROIC minus cost of capital-9.6 pp-3.5 pp5th lowest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
Zhejiang Sunflower Great Health 300111.SZChina$635M-15%-20%-10%16.2×n/an/a
Zhejiang Founder Motor 002196.SZChina$634M-35%+26%0%1.8×n/an/a
Eos Energy Enterprises EOSEUnited States$634M-78%+534%-159%7.7×n/an/a
Jiangsu Huachen Transformer 603097.SSChina$629M-4%+13%2%2.3×27.8%+27.0%
Powerica POWERICA.NSIndia$628M-5%+14%8%2.0×n/an/a
Hubei Wanrun New Energy Technology 688275.SSChina$648M-67%+146%4%0.6×n/an/a
Sanbian Sci-Tech 002112.SZChina$617M-37%+7%1%2.1×59.0%+13.2%
Wuxi New Hongtai Electrical Technology 603016.SSChina$614M-50%-4%10%6.0×36.8%+6.7%
Jiangsu SINOJIT Wind Energy Technology 601218.SSChina$657M-30%+28%8%2.1×0.3%-7.2%
Henan Carve Electronics Technology 301182.SZChina$657M-34%+32%-17%5.1×n/an/a
CyberPower Systems 3617.TWTaiwan$610M+11%0%19%1.4×-10.8%+5.4%
Henan Tong-Da Cable 002560.SZChina$607M-47%+16%2%0.6×16.2%+32.9%
Allis Electric 1514.TWTaiwan$665M-32%+24%10%2.0×8.9%+15.6%
Enovix ENVXUnited States$606M-58%+35%-497%18.7×n/an/a
Guangdong Greenway Technology 688345.SSChina$668M-17%+39%3%1.5×n/an/a
Shenzhen Bromake New Material 301387.SZChina$602M-45%+25%-1%2.1×n/an/a
Suzhou Huazhijie Telecom 603400.SSChina$675M-36%+14%8%3.1×n/an/a
VITZROCELL 082920.KSSouth Korea$675M-64%+21%28%2.8×-7.9%+16.5%
Nano Nuclear Energy NNEUnited States$597M-60%n/a-24,545%88.0×n/an/a
Jiangsu Yangdian Science & Technology 301012.SZChina$596M-43%0%5%3.3×14.5%+23.9%
Huarui Electrical Appliance 300626.SZChina$678M-6%+7%5%5.5×45.1%+2.5%

Questions

Which companies are Zhejiang Sunflower Great Health's closest peers?
The cockpit's peer set: Zhejiang Founder Motor (002196.SZ), Eos Energy Enterprises (EOSE), Jiangsu Huachen Transformer (603097.SS), Powerica (POWERICA.NS), Hubei Wanrun New Energy Technology (688275.SS), Sanbian Sci-Tech (002112.SZ), Wuxi New Hongtai Electrical Technology (603016.SS), Jiangsu SINOJIT Wind Energy Technology (601218.SS).
Is Zhejiang Sunflower Great Health expensive compared with its peers?
On ev / sales it trades at 16.2× against a peer median of 2.2×, 3rd most expensive of 21 in its peer set.
How has Zhejiang Sunflower Great Health stock performed?
Over six months to 6 Nov 2026 the shares returned -15.2% against -36.5% for the median peer; over one year -59.2%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.